The study “Improvement of Phenolic Compound Extraction by Using Ion Exchange Chromatography and Evaluation of Biological Activities of Polyphenol-enriched Fraction of Rosa canina Fruits” by Zahra Sabahi et al. (2022) examined whether a more concentrated polyphenol fraction from Rosa canina fruits could be produced and whether that enriched fraction would show stronger biological activity than the original extract. This summary paraphrases only the scientific paper. The researchers used Amberlite XAD-7 chromatography to remove unwanted compounds, then compared the extract and the enriched fraction for phenolic content, antioxidant activity, ascorbic acid content, xanthine oxidase activity, and protection against oxidative DNA damage in human lymphocytes.

The scientific paper explains that Rosa canina, often called rose hip, has a long history of traditional use in medicine and in the food, perfume, and cosmetic industries. The authors note that it has been used since ancient times and has been recommended in traditional Persian medicine for several health-related purposes. They also point out that rose hips have attracted attention in modern research because they contain vitamins, fatty acids, minerals, and numerous phytochemicals.

The study focuses on phenolic compounds. The authors explain that medicinal plants are important antioxidant sources and that phenolic compounds are “mainly responsible for these effects.” They also report a strong link between phenolic content and antioxidant activity. In simple terms, the researchers wanted to see whether concentrating those compounds could make the fruit fraction biologically stronger.

A major goal of the study was to improve extraction efficiency. The paper explains that many enrichment methods can be slow, costly, or dependent on toxic organic solvents. The authors describe Amberlite resins as a quicker, lower-cost, and safer option for enriching certain classes of compounds. Their main idea was that Amberlite XAD-7 could remove “nonaromatic polar compounds such as polysaccharides and protein” and leave behind a fraction richer in phenolic compounds.

That matters because stronger enrichment could lead to stronger biological activity. The study did not just ask whether Rosa canina had useful compounds. It asked whether a better extraction approach could produce a fraction with more concentrated antioxidant and protective effects than the starting extract.

The researchers manually harvested Rosa canina fruits in Iran, freeze-dried them, ground them into powder, and first made a total extract with ethanol. That extract then underwent additional steps, including suspension in trifluoroacetic acid (TFA), repeated ethyl acetate extractions, and loading onto a chromatography column containing Amberlite XAD-7. The methanol: TFA-eluted portion was collected as the phenolic-enriched fraction, also called the PEF. The reported yield of that fraction was 20%.

The scientific paper then compared the total extract and the enriched fraction using several lab methods. Total phenolic compounds were measured with the Folin-Ciocalteu method, flavonoids by colorimetric assay, and anthocyanins by a previously described method. Ascorbic acid was measured with high-performance liquid chromatography (HPLC). Antioxidant activity was tested by 2,2-diphenyl-1-picrylhydrazyl (DPPH), nitric oxide scavenging, ferric-reducing antioxidant power (FRAP), 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) radical scavenging (ABTS), oxygen radical absorbance capacity (ORAC), and cellular antioxidant activity (CAA).

The team also tested xanthine oxidase (XO) inhibition using a commercial enzyme assay kit and studied DNA protection using a comet assay in human lymphocytes exposed to hydrogen peroxide. That gave the paper a broad design. It did not rely on a single antioxidant test and also included cell-based damage testing to assess whether the enriched fraction showed protective effects in a more biologically relevant setting.

The first main result was that Amberlite XAD-7 enrichment clearly increased the concentration of key phytochemicals. Total phenolic content increased from 186.71 ± 0.72 mg gallic acid equivalents per gram in the extract to 325.02 ± 0.13 mg in the phenolic-enriched fraction. Total flavonoids rose from 73.63 ± 0.42 mg quercetin equivalents per gram to 164.20 ± 0.30 mg, and total anthocyanins increased from 0.11 ± 0.003 mg/g to 1.8 ± 0.19 mg/g. The paper says these increases were significant at P < 0.0001.

This is the foundation of the study. The enrichment step worked. The authors state that the fraction showed a “significant increase in total phenol, flavonoid, and anthocyanin content” compared with the extract. That stronger chemical profile helped explain the later biological results.

The fraction was not rich in phenolics alone. HPLC analysis showed that the PEF also contained ascorbic acid, with a reported concentration of 7.51 ± 0.26 mg/g. The authors specifically note that HPLC analysis showed the fraction was “a rich source of ascorbic acid.” That is important because vitamin C may add to the antioxidant profile of the fraction, even though the study focused mainly on phenolic enrichment.

The enriched fraction outperformed the original extract in several antioxidant assays. In DPPH testing, the extract had an IC50 of 476 ± 0.50 µg/mL, while the PEF had an IC50 of 57 ± 0.57 µg/mL. In the ABTS assay, the extract showed 720 ± 1.2 µg/mL, while the PEF showed 58 ± 0.5 µg/mL. In FRAP, the extract was 39 ± 0.03 µg/mL, and the fraction was 7 ± 0.01 µg/mL. Nitric oxide scavenging also rose from 53.22 ± 1.25% in the extract to 91.16 ± 0.69% in the fraction at 200 µg/mL.

The paper also added two extra antioxidant measures for the PEF. In ORAC testing, the phenolic-enriched fraction had a value of 1.05 ± 0.04 Trolox equivalents, compared with 0.72 ± 0.021 for quercetin. In the CAA assay, the fraction had an EC50 of 82.19 ± 0.42 µg/mL, indicating that it could reduce oxidative stress in cells. The authors write that “the antioxidant activities of the fraction had been increased compared to the extract,” and the numbers support that claim.

Another important finding was the xanthine oxidase result. The paper reports that the PEF showed 95.4 ± 0.001% xanthine oxidase inhibition, while ascorbic acid showed 90.26 ± 0.003% under the assay conditions used. The authors interpret this as meaningful because xanthine oxidase plays a key role in purine metabolism and has been linked in the paper to hyperuricemia, gout, cardiovascular disease, hypertension, and metabolic syndrome.

This does not prove a clinical effect in humans, since the work was done in the lab. Still, within the boundaries of the scientific paper, the enriched fraction showed strong enzyme inhibition and was described as a potential xanthine oxidase inhibitor.

The comet assay gave the study another layer of evidence. Human lymphocytes exposed to hydrogen peroxide alone showed significant DNA strand breaks. However, cells exposed to hydrogen peroxide at 25, 50, and 100 µg/mL showed lower DNA damage, with significance at P < 0.05. The paper states that these concentrations “inhibited H2O2 genotoxicity in human lymphocytes.”

The authors suggest that phenolic compounds may help by scavenging radicals before those radicals damage DNA. They also discuss metal-chelating effects that may help reduce Fenton-type reactions. In simple terms, the fraction seemed to protect cells from oxidative injury in this lab model.

The main implication of the scientific paper is that enrichment significantly improved the material's quality. Amberlite XAD-7 did not just produce a different fraction. It produced one that was richer in phenolic compounds, stronger in antioxidant tests, active against xanthine oxidase, and more protective in the comet assay than the starting extract.

The findings also show why the extraction method matters in plant research. The paper argues that Rosa canina's biological activity can be enhanced by removing unwanted compounds and concentrating active compounds. That is why the authors conclude that Amberlite XAD-7 “improves extraction efficiencies through enrichment of phenolic compounds.”

Still, the study should be read carefully. These are lab-based findings, not human clinical outcomes. The evidence supports antioxidant, xanthine oxidase inhibitory, and antigenotoxic potential in the tested systems, but it does not prove treatment effects in patients. The best reading is that this is a strong preclinical study pointing to promising uses for a polyphenol-enriched rose hip fraction.

This paraphrased summary of the scientific paper points to a clear conclusion: Amberlite XAD-7 enrichment made the Rosa canina fruit fraction richer in phenols, flavonoids, anthocyanins, and ascorbic acid, and that enriched fraction showed stronger biological activity than the original extract. Based on the study alone, the fraction looks promising as a preclinical antioxidant, xanthine oxidase inhibitor, and DNA-protective source, but the findings remain laboratory evidence that still needs follow-up in clinical settings.